The increased expression of BRD4, p300 and CBP results in the progression of AR-dependent PCa, and they are all associated with PCa tumorigenesis and poor prognosis [22,41], rendering these proteins interesting therapeutic targets. This evidence concerns the gene AR and posterior cortical atrophy.